March 20, 2026

Clinical research continues to evolve at an impressive pace. Digital technologies streamline data capture, biomarkers deepen biological insight, and innovative trial designs broaden access for diverse populations. These advances have unquestionably accelerated development and expanded participant reach. Still, across all this progress, one dimension consistently shapes outcomes yet remains underrepresented in planning, modeling, and oversight: patient behavior.    Behavioral factors like motivation,

March 13, 2026
Cognivia's CEO Dominique Demolle at FORTREA

We are pleased to announce that Cognivia will participate in the Fortrea Innovation & Technology Summit in Boston on April 7, 2026. Our CEO, Dominique Demolle, will join the industry panel: “User Experience and Adoption Strategies: Why a Great Product Is Only One Factor in Success.” Speakers: This panel will explore how user experience, adoption

March 11, 2026
Sapa conference 2026 invited cognivia's ceo for a round table discussion

We are pleased to share that Cognivia will take part in the SAPA Annual Conference in Philadelphia on March 21, 2026. Our CEO, Dominique Demolle, will join the round‑table discussion: “From Data to ROI: How AI Impacts the Bottom Line of Drug Development.” Speakers: This session will explore how AI‑driven insights translate into measurable value

February 5, 2026

Patient retention or patient engagement have become a main operational challenge in today’s clinical trials. Despite major investments in decentralized models, engagement tools, and site‑facing technology, patient drop‑out still catches clinical operations teams by surprise. And when it does, the impact on timelines, data quality, and site oversight is immediate. A new upcoming webinar from Cognivia

October 9, 2025
cognivia signal launch

Cognivia launches the world’s first early-warning behavioral risk intelligence dashboard—Cognivia Signal—empowering clinical teams to see what’s coming before it happens. Mont-Saint-Guibert, Belgium – October 9, 2025 – Cognivia, the AI-driven leader in behavioral science for clinical research, proudly announces the launch of Cognivia Signal, a groundbreaking solution designed to transform how clinical trial sponsors manage behavioral risk.